C96 CRITICAL CARE: NEW DISCOVERIES IN ARDS: Elevated Plasma Concentrations Of Soluble Suppressor Of Tumorigenicity-2 (sst2) Accurately Discriminates Acute Respiratory Distress Syndrome From Acute Heart Failure

Rationale: The distinction between acute heart failure (AHF) and acute respiratory distress syndrome (ARDS), two common causes of acute hypoxemic respiratory failure with considerable morbidity, can be challenging. Serum concentrations of soluble suppressor of tumorigenicity-2 (sST2), a member of th...

Full description

Saved in:
Bibliographic Details
Published in:American journal of respiratory and critical care medicine 2017-01, Vol.195
Main Authors: Levy, S D, Thompson, B T, Matthay, M A, Januzzi, J L, Christiani, D C, Bajwa, E
Format: Article
Language:English
Subjects:
Heart failure
Respiratory distress syndrome
Respiratory therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page
container_title American journal of respiratory and critical care medicine
container_volume 195
creator Levy, S D
Thompson, B T
Matthay, M A
Januzzi, J L
Christiani, D C
Bajwa, E
description Rationale: The distinction between acute heart failure (AHF) and acute respiratory distress syndrome (ARDS), two common causes of acute hypoxemic respiratory failure with considerable morbidity, can be challenging. Serum concentrations of soluble suppressor of tumorigenicity-2 (sST2), a member of the interleukin-1 receptor family that plays a key role in in both endothelial and epithelial signaling pathways, has been shown to be highly prognostic in ARDS, and may have a diagnostic role as well.
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1926867238</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1926867238</sourcerecordid><originalsourceid>FETCH-proquest_journals_19268672383</originalsourceid><addsrcrecordid>eNqNjN1Kw0AQhYMoWH_eYcAbvQjkr2nTu7BNaUBaSYp6V9Z0Kls2u3FnV-hj-kZupQ_gzZk58505F8EoHqfjMCsm0aXfo0kaZlnxfh3cEB2iKE6mcTQKfliRA2vqTc3KZ2BlU81gVb3BvG7Z-rVq6qqFegVlM29nUEn85hZ38CI59RyYVh0qa7gVWhGs99Bq6T4kQuuGwSCRNqfrxvXaiE9UohP2GCbwSGSTJyi7zvlnlEeYC-qM6IXyljxwFqFBGoTn2vxxeyqE9qh2RvcIC6_n4BK5sbDgQjqDd8HVnkvC-_O8DR4W1YYtw8HoL4dktwftjPJoGxdJPs0nSTpN_5f6BUt4a30</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1926867238</pqid></control><display><type>article</type><title>C96 CRITICAL CARE: NEW DISCOVERIES IN ARDS: Elevated Plasma Concentrations Of Soluble Suppressor Of Tumorigenicity-2 (sst2) Accurately Discriminates Acute Respiratory Distress Syndrome From Acute Heart Failure</title><source>Freely Accessible Journals</source><source>EZB Electronic Journals Library</source><creator>Levy, S D ; Thompson, B T ; Matthay, M A ; Januzzi, J L ; Christiani, D C ; Bajwa, E</creator><creatorcontrib>Levy, S D ; Thompson, B T ; Matthay, M A ; Januzzi, J L ; Christiani, D C ; Bajwa, E</creatorcontrib><description>Rationale: The distinction between acute heart failure (AHF) and acute respiratory distress syndrome (ARDS), two common causes of acute hypoxemic respiratory failure with considerable morbidity, can be challenging. Serum concentrations of soluble suppressor of tumorigenicity-2 (sST2), a member of the interleukin-1 receptor family that plays a key role in in both endothelial and epithelial signaling pathways, has been shown to be highly prognostic in ARDS, and may have a diagnostic role as well.</description><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><language>eng</language><publisher>New York: American Thoracic Society</publisher><subject>Heart failure ; Respiratory distress syndrome ; Respiratory therapy</subject><ispartof>American journal of respiratory and critical care medicine, 2017-01, Vol.195</ispartof><rights>Copyright American Thoracic Society 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781</link.rule.ids></links><search><creatorcontrib>Levy, S D</creatorcontrib><creatorcontrib>Thompson, B T</creatorcontrib><creatorcontrib>Matthay, M A</creatorcontrib><creatorcontrib>Januzzi, J L</creatorcontrib><creatorcontrib>Christiani, D C</creatorcontrib><creatorcontrib>Bajwa, E</creatorcontrib><title>C96 CRITICAL CARE: NEW DISCOVERIES IN ARDS: Elevated Plasma Concentrations Of Soluble Suppressor Of Tumorigenicity-2 (sst2) Accurately Discriminates Acute Respiratory Distress Syndrome From Acute Heart Failure</title><title>American journal of respiratory and critical care medicine</title><description>Rationale: The distinction between acute heart failure (AHF) and acute respiratory distress syndrome (ARDS), two common causes of acute hypoxemic respiratory failure with considerable morbidity, can be challenging. Serum concentrations of soluble suppressor of tumorigenicity-2 (sST2), a member of the interleukin-1 receptor family that plays a key role in in both endothelial and epithelial signaling pathways, has been shown to be highly prognostic in ARDS, and may have a diagnostic role as well.</description><subject>Heart failure</subject><subject>Respiratory distress syndrome</subject><subject>Respiratory therapy</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqNjN1Kw0AQhYMoWH_eYcAbvQjkr2nTu7BNaUBaSYp6V9Z0Kls2u3FnV-hj-kZupQ_gzZk58505F8EoHqfjMCsm0aXfo0kaZlnxfh3cEB2iKE6mcTQKfliRA2vqTc3KZ2BlU81gVb3BvG7Z-rVq6qqFegVlM29nUEn85hZ38CI59RyYVh0qa7gVWhGs99Bq6T4kQuuGwSCRNqfrxvXaiE9UohP2GCbwSGSTJyi7zvlnlEeYC-qM6IXyljxwFqFBGoTn2vxxeyqE9qh2RvcIC6_n4BK5sbDgQjqDd8HVnkvC-_O8DR4W1YYtw8HoL4dktwftjPJoGxdJPs0nSTpN_5f6BUt4a30</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Levy, S D</creator><creator>Thompson, B T</creator><creator>Matthay, M A</creator><creator>Januzzi, J L</creator><creator>Christiani, D C</creator><creator>Bajwa, E</creator><general>American Thoracic Society</general><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20170101</creationdate><title>C96 CRITICAL CARE: NEW DISCOVERIES IN ARDS: Elevated Plasma Concentrations Of Soluble Suppressor Of Tumorigenicity-2 (sst2) Accurately Discriminates Acute Respiratory Distress Syndrome From Acute Heart Failure</title><author>Levy, S D ; Thompson, B T ; Matthay, M A ; Januzzi, J L ; Christiani, D C ; Bajwa, E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_19268672383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Heart failure</topic><topic>Respiratory distress syndrome</topic><topic>Respiratory therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Levy, S D</creatorcontrib><creatorcontrib>Thompson, B T</creatorcontrib><creatorcontrib>Matthay, M A</creatorcontrib><creatorcontrib>Januzzi, J L</creatorcontrib><creatorcontrib>Christiani, D C</creatorcontrib><creatorcontrib>Bajwa, E</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Levy, S D</au><au>Thompson, B T</au><au>Matthay, M A</au><au>Januzzi, J L</au><au>Christiani, D C</au><au>Bajwa, E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>C96 CRITICAL CARE: NEW DISCOVERIES IN ARDS: Elevated Plasma Concentrations Of Soluble Suppressor Of Tumorigenicity-2 (sst2) Accurately Discriminates Acute Respiratory Distress Syndrome From Acute Heart Failure</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><date>2017-01-01</date><risdate>2017</risdate><volume>195</volume><issn>1073-449X</issn><eissn>1535-4970</eissn><abstract>Rationale: The distinction between acute heart failure (AHF) and acute respiratory distress syndrome (ARDS), two common causes of acute hypoxemic respiratory failure with considerable morbidity, can be challenging. Serum concentrations of soluble suppressor of tumorigenicity-2 (sST2), a member of the interleukin-1 receptor family that plays a key role in in both endothelial and epithelial signaling pathways, has been shown to be highly prognostic in ARDS, and may have a diagnostic role as well.</abstract><cop>New York</cop><pub>American Thoracic Society</pub></addata></record>
fulltext fulltext
identifier ISSN: 1073-449X
ispartof American journal of respiratory and critical care medicine, 2017-01, Vol.195
issn 1073-449X
1535-4970
language eng
recordid cdi_proquest_journals_1926867238
source Freely Accessible Journals; EZB Electronic Journals Library
subjects Heart failure
Respiratory distress syndrome
Respiratory therapy
title C96 CRITICAL CARE: NEW DISCOVERIES IN ARDS: Elevated Plasma Concentrations Of Soluble Suppressor Of Tumorigenicity-2 (sst2) Accurately Discriminates Acute Respiratory Distress Syndrome From Acute Heart Failure
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T13%3A54%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=C96%20CRITICAL%20CARE:%20NEW%20DISCOVERIES%20IN%20ARDS:%20Elevated%20Plasma%20Concentrations%20Of%20Soluble%20Suppressor%20Of%20Tumorigenicity-2%20(sst2)%20Accurately%20Discriminates%20Acute%20Respiratory%20Distress%20Syndrome%20From%20Acute%20Heart%20Failure&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=Levy,%20S%20D&rft.date=2017-01-01&rft.volume=195&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/&rft_dat=%3Cproquest%3E1926867238%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_19268672383%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1926867238&rft_id=info:pmid/&rfr_iscdi=true